Christopher Enny
Impact in
- Biochemistry top 2%
- Blood transfusion and management
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Erythropoietin and Anemia Treatment 4
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Cancer therapeutics and mechanisms 2
- Co-authors
- Howard L. Corwin (4 shared papers)Ronald G. Pearl (3 shared papers)Robert M. Rodriguez (3 shared papers)K. Dean Gubler (3 shared papers)Michael J. Corwin (3 shared papers)Theodore Colton (3 shared papers)Andrew Gettinger (3 shared papers)Helgi van de Velde (11 shared papers)
- Journals
- Blood (5 papers)Critical Care Medicine (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)QJM (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Christopher Enny
21 papers receiving 970 citations
Peers
Comparison fields: 5 of 55
- Biochemistry 221
- Hematology 383
- Critical Care and Intensive Care Medicine 97
- Genetics 204
- Nephrology 68
Countries citing papers authored by Christopher Enny
This map shows the geographic impact of Christopher Enny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Enny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Enny more than expected).
Fields of papers citing papers by Christopher Enny
This network shows the impact of papers produced by Christopher Enny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Enny. The network helps show where Christopher Enny may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Enny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 243 | |
| 2 | 2011 | 127 | |
| 3 | 2015 | 101 | |
| 4 | 2011 | 89 | |
| 5 | 2009 | 69 | |
| 6 | 2008 | 61 | |
| 7 | 2006 | 60 | |
| 8 | 2012 | 58 | |
| 9 | 2014 | 57 | |
| 10 | 2011 | 37 | |
| 11 | 2015 | 21 | |
| 12 | 2001 | 21 | |
| 13 | 2012 | 17 | |
| 14 | 2017 | 15 | |
| 15 | 2010 | 11 | |
| 16 | 2009 | 5 | |
| 17 | 1998 | 4 | |
| 18 | Phase II study of bortezomib, thalidomide, and dexamethasone /- cyclophosphamide as induction therapy in previously untreated multiple myeloma (MM): safety and activity including evaluation of MRD | 2010 | 4 |
| 19 | 2022 | 3 | |
| 20 | Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy | 2011 | 1 |
About Christopher Enny
Christopher Enny is a scholar working on Hematology, Molecular Biology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (4 papers), Erythropoietin and Anemia Treatment (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Viral-associated cancers and disorders (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Biochemistry (221 citations), Hematology (383 citations), Critical Care and Intensive Care Medicine (97 citations), Genetics (204 citations) and Nephrology (68 citations). Christopher Enny has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Howard L. Corwin, Ronald G. Pearl, Robert M. Rodriguez, K. Dean Gubler, Michael J. Corwin, Theodore Colton, Andrew Gettinger, Helgi van de Velde, Wayne Langholff and Dixie‐Lee Esseltine. Their work appears in journals such as Blood, Critical Care Medicine, Journal of Clinical Oncology, British Journal of Haematology and QJM.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.